Advertisement
DAILY / MAY 4, 2014, VOL. 4, NO. 19   Send Feedback l View Online
Psychiatric News Update
The Voice of the American Psychiatric Association and the Psychiatric Community
 BACK TO NEWSLETTER  ::  CURRENT ISSUE  ::  PN ARCHIVES  ::  NEWS ALERT  ::  CONTACT US 
  
twitter facebook facebook
2014 APA's Annual Meeting Special Edition

Expert Discusses Pharmacological Interventions for Elderly

Sandra Jacobson, M.D.Pharmacologic intervention on the C/L service was the focus of a workshop presented today by Sandra Jacobson, M.D., author of the second edition of the Clinical Manual of Geriatric Psychopharmacology, just published by American Psychiatric Publishing.

The workshop covered advanced practices of diagnosis and treatment involving a variety of syndromes—catatonia, neuroleptic sensitivity, serotonin syndrome, akathisia, tardive dyskinesia, and nonconvulsive status epilepticus—as well as issues such as psychotropic use in patients with hepatic or renal impairment. Each topic was introduced with a real-world clinical vignette, and then participants focused on specific diagnostic and treatment issues. In the discussion of catatonia, for example, the question was raised whether catatonia may be misdiagnosed as delirium. To make the diagnosis, the consultant has to be considering catatonia, because the classic motor signs have to be elicited. In addition, although EEG can be useful in distinguishing catatonia from delirium, EEG rarely is recommended by psychiatric consultants in current practice. Participants agreed that the treatment algorithms for delirium and catatonia diverge significantly, such that a wrong diagnosis could result in ineffective or even harmful treatment.

The benzodiazepine challenge test for catatonia was reviewed in detail, along with techniques to elicit the motor signs of serotonin syndrome. In addition, the potential for underdiagnosis of serotonin syndrome according to the Hunter criteria was noted. In the discussion of akathisia, the role of anti-adrenergic drugs was explained using a model proposed by Loonen and Stahl in 2011. The point was made that anticholinergic drugs have no role in the treatment of this syndrome. For rapid control of severe akathisia, IV propranolol and benzodiazepines were recommended. For more routine treatment, oral propranolol, oral lorazepam, or clonidine was suggested.

Newly proposed treatments for akathisia hypothesized to work by 5HT2A antagonism—including trazodone and mirtazapine—were discussed. The use of tetrabenazine to treat tardive dyskinesia—including more serious and unusual syndromes such as respiratory dyskinesia—was reviewed. Also discussed was the need to establish a routine of evaluating hepatic and renal function of hospitalized C/L patients before psychotropic medication is recommended, so that dosage and schedule adjustments can be made. Methods for rapid estimation of glomerular filtration rate using the Web-based GFR (MDRD) calculator and of potential hepatic injury using Hy’s law were described.

For more information on the Clinical Manual of Geriatric Psychopharmacology, click here. APA members may purchase the book at a discount online or at the annual meeting.

Advertisement

Advertisement


blog

 subscribe to blog rss

>>subscribe to blog via email

Copyright © 2014 American Psychiatric Association. All rights reserved.

Advertisement